首页 > 最新文献

The Baxter health policy review最新文献

英文 中文
States and health care reform: the importance of program implementation. 国家与卫生保健改革:方案实施的重要性。
Pub Date : 1996-01-01
D F Beatrice

The recent debate on national health care reform marked another case of policy being considered without reference to how--or even if--it could be implemented. The debate revolved around broad issues, such as universal versus partial coverage, mandatory versus voluntary alliances, and the respective roles of government and the market in health care. The ease or even the possibility of successful implementation was not an ingredient in evaluating proposals. The burden of making health care reform work falls to the states. Whether in response to national reform or in implementing their own programs, they must move from a general reform blueprint to an actual program that delivers services. The hands-on role of the states in designing and operating programs makes their implementation duties both unavoidable and critical. This chapter explores implementation issues that should be considered an integral part of planning for health care reform, at both the federal and the state level. The chapter has two goals. First, it makes a case for altering the usual approach to designing reform and recommends paying attention to implementation early in the policy process, rather than treating it as an afterthough. Second, it is intended to help policymakers design implementable programs and anticipate pitfalls. To achieve these goals, it examines the state role in health care reform; state capacity to carry out this role; examples of state health care reform initiatives and lessons for implementation drawn from these efforts; and barriers to successful implementation. The chapter concludes with recommendations for policymakers.

最近关于国家医疗改革的辩论标志着另一个在考虑政策时不考虑如何实施——甚至不考虑是否可以实施——的例子。辩论围绕着广泛的问题展开,例如普遍覆盖还是部分覆盖、强制性联盟还是自愿联盟,以及政府和市场在卫生保健中的各自作用。成功执行的难易程度,甚至成功执行的可能性,都不是评价建议的一个因素。医疗改革的重任落在了各州的肩上。无论是应对国家改革还是实施自己的方案,它们都必须从总体改革蓝图转向提供服务的实际方案。各州在设计和操作程序方面的实际作用使其执行职责既不可避免又至关重要。本章探讨了应被视为联邦和州一级卫生保健改革规划的组成部分的实施问题。本章有两个目的。首先,它提出了改变设计改革的通常方法的理由,并建议在政策过程的早期注意执行,而不是把它当作事后处理。其次,它旨在帮助政策制定者设计可实施的计划并预测陷阱。为实现这些目标,报告审查了国家在医疗改革中的作用;国家发挥这一作用的能力;国家卫生保健改革举措的例子和从这些努力中吸取的实施教训;以及成功实施的障碍。本章最后对政策制定者提出了建议。
{"title":"States and health care reform: the importance of program implementation.","authors":"D F Beatrice","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>The recent debate on national health care reform marked another case of policy being considered without reference to how--or even if--it could be implemented. The debate revolved around broad issues, such as universal versus partial coverage, mandatory versus voluntary alliances, and the respective roles of government and the market in health care. The ease or even the possibility of successful implementation was not an ingredient in evaluating proposals. The burden of making health care reform work falls to the states. Whether in response to national reform or in implementing their own programs, they must move from a general reform blueprint to an actual program that delivers services. The hands-on role of the states in designing and operating programs makes their implementation duties both unavoidable and critical. This chapter explores implementation issues that should be considered an integral part of planning for health care reform, at both the federal and the state level. The chapter has two goals. First, it makes a case for altering the usual approach to designing reform and recommends paying attention to implementation early in the policy process, rather than treating it as an afterthough. Second, it is intended to help policymakers design implementable programs and anticipate pitfalls. To achieve these goals, it examines the state role in health care reform; state capacity to carry out this role; examples of state health care reform initiatives and lessons for implementation drawn from these efforts; and barriers to successful implementation. The chapter concludes with recommendations for policymakers.</p>","PeriodicalId":80306,"journal":{"name":"The Baxter health policy review","volume":"2 ","pages":"183-206"},"PeriodicalIF":0.0,"publicationDate":"1996-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"21894427","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The role of quality measurement in a competitive marketplace. 质量测量在竞争市场中的作用。
Pub Date : 1996-01-01
A M Epstein

Quality measurement is not a new idea. However, in recent years, several new trends have gained prominence: greater interest in publicly reported information on quality of care, access to care, and patient satisfaction; an increased focus on health plans and integrated systems of care rather than on institutional providers and practitioners as the unit of observation; wide adoption of the techniques of continuous quality improvement within the health care sector; increased use of clinical practice guidelines to improve care for a broad range of medical conditions; incorporation of computer technology into the clinical setting; and greater appreciation for health outcomes as a measure of quality of care. This chapter first reviews the changes in the medical landscape that have seeded these trends and the distinction between quality assurance and quality improvement. It then focuses on public policy concerns, in particular on the emergence of publicly disseminated information about quality of care, now often called "quality report cards." The major prototypes of these reports developed to date, the responses to quality reporting by different members of the delivery system, and the major criticisms of this approach are reviewed. The chapter concludes by predicting probable developments and the strategies most likely to move health care forward in a productive direction.

质量度量并不是一个新概念。然而,近年来,有几个新趋势得到了突出:对公开报道的医疗质量、获得医疗服务和患者满意度的信息更感兴趣;更加注重保健计划和综合保健系统,而不是把机构提供者和从业人员作为观察单位;在保健部门内广泛采用持续改进质量的技术;增加临床实践指南的使用,以改善对各种医疗条件的护理;计算机技术在临床环境中的应用;更重视健康结果,将其作为医疗质量的衡量标准。本章首先回顾了医学领域的变化,这些变化已经播下了这些趋势的种子,以及质量保证和质量改进之间的区别。然后重点关注公共政策问题,特别是关于医疗质量的公开传播信息的出现,现在通常被称为“质量报告卡”。审查了迄今为止编制的这些报告的主要原型、执行系统不同成员对高质量报告的反应以及对这种方法的主要批评。本章最后预测了可能的发展和最有可能将卫生保健推向富有成效的方向的战略。
{"title":"The role of quality measurement in a competitive marketplace.","authors":"A M Epstein","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Quality measurement is not a new idea. However, in recent years, several new trends have gained prominence: greater interest in publicly reported information on quality of care, access to care, and patient satisfaction; an increased focus on health plans and integrated systems of care rather than on institutional providers and practitioners as the unit of observation; wide adoption of the techniques of continuous quality improvement within the health care sector; increased use of clinical practice guidelines to improve care for a broad range of medical conditions; incorporation of computer technology into the clinical setting; and greater appreciation for health outcomes as a measure of quality of care. This chapter first reviews the changes in the medical landscape that have seeded these trends and the distinction between quality assurance and quality improvement. It then focuses on public policy concerns, in particular on the emergence of publicly disseminated information about quality of care, now often called \"quality report cards.\" The major prototypes of these reports developed to date, the responses to quality reporting by different members of the delivery system, and the major criticisms of this approach are reviewed. The chapter concludes by predicting probable developments and the strategies most likely to move health care forward in a productive direction.</p>","PeriodicalId":80306,"journal":{"name":"The Baxter health policy review","volume":"2 ","pages":"207-34"},"PeriodicalIF":0.0,"publicationDate":"1996-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"21895008","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The special health care needs of the elderly. 老年人的特殊保健需要。
Pub Date : 1996-01-01
M Moon

Interest in Medicare, the government's second largest social program after Social Security, reached a new high in 1995, not as part of health care reform, but as a vehicle for deficit reduction and because of a desire by Congress to restructure the program to encourage enhanced choice for beneficiaries and greater use of managed care. Medicaid, a major payer of long-term care and financer of coverage for low-income elderly, also is slated to undergo major restructuring in the next few years. As Congress and the nation debate the future of these key programs for older Americans, a number of critical issues deserve attention. Medicare's costs are very high--but not necessarily unreasonable in the face of the demands on health care services for this part of the population. And even with these high costs, a number of important gaps in coverage remain a problem for seniors. Deductibles and copayments are also high--especially for hospital and skilled nursing services. But pressure for change may well lead to higher, not lower, cost-sharing requirements. Medicare remains a largely fee-for-service program at a time when the national health care system is shifting increasingly to a managed care environment. Moving Medicare in that direction is one likely option for change. While it is desirable to have Medicare move in concert with the rest of the system, a number of issues stand in the way of an effortless move to managed care for the elderly. Moreover, coordination of long-term and acute care services may be even more challenging in such an environment. Medicaid covers long-term care services for older Americans, but only for those who have depleted most of their assets and income. Even when people do become eligible, Medicaid covers primarily institutional care. But little is likely to change this picture in the next few years, and private efforts through expansion of long-term care insurance will likely provide only a partial solution.

人们对医疗保险的兴趣在1995年达到了新高,这不是作为医疗改革的一部分,而是作为削减赤字的工具,也因为国会希望重组该计划,以鼓励受益人有更多的选择,并更多地使用管理式医疗。医疗补助计划是长期护理的主要支付方,也是低收入老年人医疗保险的主要资助方,该计划也将在未来几年内进行重大重组。在国会和全国就这些针对美国老年人的关键项目的未来展开辩论之际,有一些关键问题值得关注。医疗保险的成本非常高,但面对这部分人口对医疗服务的需求,这并不一定是不合理的。即使有这么高的成本,在覆盖范围上的一些重要差距仍然是老年人的一个问题。免赔额和共付额也很高,尤其是医院和专业护理服务。但是变革的压力很可能导致更高而不是更低的成本分摊要求。在国家医疗保健系统日益转向管理式医疗环境的时候,医疗保险仍然是一个很大程度上按服务收费的项目。将医疗保险推向这个方向是一个可能的改变选择。虽然医疗保险与系统的其他部分协调一致是可取的,但许多问题阻碍了对老年人进行管理式护理的轻松行动。此外,在这种环境下,长期和急症护理服务的协调可能更具挑战性。医疗补助为美国老年人提供长期护理服务,但只针对那些已经耗尽了大部分资产和收入的人。即使人们确实符合资格,医疗补助也主要覆盖机构医疗。但是在接下来的几年里,这种情况不太可能改变,私人通过扩大长期护理保险的努力可能只会提供部分解决方案。
{"title":"The special health care needs of the elderly.","authors":"M Moon","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Interest in Medicare, the government's second largest social program after Social Security, reached a new high in 1995, not as part of health care reform, but as a vehicle for deficit reduction and because of a desire by Congress to restructure the program to encourage enhanced choice for beneficiaries and greater use of managed care. Medicaid, a major payer of long-term care and financer of coverage for low-income elderly, also is slated to undergo major restructuring in the next few years. As Congress and the nation debate the future of these key programs for older Americans, a number of critical issues deserve attention. Medicare's costs are very high--but not necessarily unreasonable in the face of the demands on health care services for this part of the population. And even with these high costs, a number of important gaps in coverage remain a problem for seniors. Deductibles and copayments are also high--especially for hospital and skilled nursing services. But pressure for change may well lead to higher, not lower, cost-sharing requirements. Medicare remains a largely fee-for-service program at a time when the national health care system is shifting increasingly to a managed care environment. Moving Medicare in that direction is one likely option for change. While it is desirable to have Medicare move in concert with the rest of the system, a number of issues stand in the way of an effortless move to managed care for the elderly. Moreover, coordination of long-term and acute care services may be even more challenging in such an environment. Medicaid covers long-term care services for older Americans, but only for those who have depleted most of their assets and income. Even when people do become eligible, Medicaid covers primarily institutional care. But little is likely to change this picture in the next few years, and private efforts through expansion of long-term care insurance will likely provide only a partial solution.</p>","PeriodicalId":80306,"journal":{"name":"The Baxter health policy review","volume":"2 ","pages":"317-49"},"PeriodicalIF":0.0,"publicationDate":"1996-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"21895011","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Health care spending: can the United States control it? 医疗保健支出:美国能控制吗?
Pub Date : 1996-01-01
S H Altman, S S Wallack

Health care spending in the United States has continued to outpace the growth in national income and the growth in spending in other countries. And yet many Americans are without sufficient health care. Since the failure of national health care reform proposals put forward by the Clinton administration and others, the United States has had to look for other solutions to the problem of how to control spending in this sector. Can the new competitive approach of managed care succeed where other cost control measures of the past have failed? This chapter begins with an examination of the problems facing health care today, outlines recent trends in health care spending, and details reasons why spending is rising so rapidly at this time. The historical context of health care reform proposals and government attempts to control spending are described next and the reasons why some of these plans made no progress are explained. The health care payment systems of other industrialized nations that have seen some success in controlling costs are analyzed. Comparison of these systems with proposed plans for reforming the U.S. system provide insights and lessons for the United States. Finally, the chapter describes managed care and managed competition and makes the argument that managed care has the potential to respond to many of the health care spending problems facing the United States. However, more data on this subject are needed, and the authors call for a national monitoring entity to assess the progress of managed care in meeting the health care needs of the public.

美国的医疗保健支出继续超过国民收入的增长和其他国家的支出增长。然而,许多美国人没有足够的医疗保健。由于克林顿政府和其他人提出的国家医疗改革建议失败,美国不得不寻找其他解决方案来控制这一部门的支出。在过去其他成本控制措施失败的情况下,管理式医疗的新竞争方法能否成功?本章首先考察了当今医疗保健面临的问题,概述了医疗保健支出的最新趋势,并详细说明了目前医疗保健支出增长如此之快的原因。医疗改革提案和政府试图控制支出的历史背景下描述,并解释了为什么这些计划没有取得进展的原因。分析了其他工业化国家在控制成本方面取得一些成功的医疗保健支付系统。将这些制度与美国提出的制度改革方案进行比较,为美国提供了见解和教训。最后,本章描述了管理式医疗保健和管理式竞争,并提出了管理式医疗保健有可能应对美国面临的许多医疗保健支出问题的论点。然而,需要更多关于这一主题的数据,作者呼吁建立一个国家监测实体来评估管理式医疗在满足公众卫生保健需求方面的进展。
{"title":"Health care spending: can the United States control it?","authors":"S H Altman,&nbsp;S S Wallack","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Health care spending in the United States has continued to outpace the growth in national income and the growth in spending in other countries. And yet many Americans are without sufficient health care. Since the failure of national health care reform proposals put forward by the Clinton administration and others, the United States has had to look for other solutions to the problem of how to control spending in this sector. Can the new competitive approach of managed care succeed where other cost control measures of the past have failed? This chapter begins with an examination of the problems facing health care today, outlines recent trends in health care spending, and details reasons why spending is rising so rapidly at this time. The historical context of health care reform proposals and government attempts to control spending are described next and the reasons why some of these plans made no progress are explained. The health care payment systems of other industrialized nations that have seen some success in controlling costs are analyzed. Comparison of these systems with proposed plans for reforming the U.S. system provide insights and lessons for the United States. Finally, the chapter describes managed care and managed competition and makes the argument that managed care has the potential to respond to many of the health care spending problems facing the United States. However, more data on this subject are needed, and the authors call for a national monitoring entity to assess the progress of managed care in meeting the health care needs of the public.</p>","PeriodicalId":80306,"journal":{"name":"The Baxter health policy review","volume":"2 ","pages":"1-32"},"PeriodicalIF":0.0,"publicationDate":"1996-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"21894420","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The legal framework for effective competition. 有效竞争的法律框架。
Pub Date : 1996-01-01
R A Berenson, D A Hastings, W G Kopit

Largely because of its indifference to spiraling costs, the professional domination model is being replaced by a market model based on competition among managed care plans and integrated delivery systems. In general, the more fully integrated previously competing providers become--for instance, by assuming financial risk together--the less legal risk is present, because of a decreased possibility of improper conspiratorial or collective behavior. Nevertheless, provider joint ventures and integrated delivery systems face a complex interaction of practical challenges and various legal and regulatory risks. This chapter explores ways in which laws involving fraud and abuse, self-referral, private inurement, corporate practice of medicine, Medicare reimbursement policy, and antitrust enforcement affect typical integrated delivery systems. From a legal standpoint, it might seem logical that the laws regulating health care providers would support and promote integration. A permissive legal environment to foster development of an integrated service network model assumes its development in a delivery system in which networks are at financial risk for the services provided. However, many of the laws and regulations governing integrated provider development were established at a time when joint ventures and other alliances were organizing in a predominantly fee-for-service environment and were generating significant increases in health care costs without producing demonstrable efficiencies or quality enhancements. The results is a fundamental inconsistency in government policy. The demand for collaboration by purchasers and legislatures does not necessarily cause the vast body of health care regulators to revise their concerns that many of the very collaborative activities being encouraged trigger potentially illegal acts and relationships. In a market model, the application of federal and state antitrust laws is especially important. In 1993 and 1994, the Department of Justice and the Federal Trade Commission jointly issued "Statements of Antitrust Enforcement Policy" in a number of areas of provider uncertainty. For integrated delivery systems, the primary focus of antitrust analysis is "market power." Systems without market power (i.e., the ability to force a purchaser to do something that the purchaser would not do in a competitive market) cannot harm consumers and should be free from serious antitrust risk. Where a network may have market power, its activities may be limited only if demonstrable anticompetitive effects outweigh the benefits of the efficiencies claimed by the new arrangement. The chapter concludes that vigorous antitrust enforcement may be required to promote market competition among integrated networks of providers and the managed care plans they serve.

由于对不断上升的成本漠不关心,专业主导模式正在被基于管理式医疗计划和综合交付系统之间竞争的市场模式所取代。一般来说,以前相互竞争的供应商越充分整合——例如,通过共同承担金融风险——存在的法律风险就越小,因为不正当阴谋或集体行为的可能性降低了。然而,供应商合资企业和综合交付系统面临着实际挑战和各种法律和监管风险的复杂相互作用。本章探讨了涉及欺诈和滥用、自我转诊、私人保险、医药企业实践、医疗保险报销政策和反垄断执法的法律如何影响典型的综合交付系统。从法律的角度来看,监管卫生保健提供者的法律支持和促进一体化似乎是合乎逻辑的。促进综合服务网络模式发展的宽松法律环境假定其发展是在一种交付系统中进行的,在这种交付系统中,网络所提供的服务面临财务风险。然而,管理综合提供者发展的许多法律和条例是在合资企业和其他联盟在主要是按服务收费的环境中组织起来的时候制定的,这些企业和联盟造成了保健费用的大幅增加,却没有产生明显的效率或质量提高。其结果是政府政策的根本不一致。购买者和立法机构对合作的要求并不一定会使大量卫生保健监管机构改变他们的担忧,即许多被鼓励的非常合作的活动可能引发非法行为和关系。在市场模型中,联邦和州反垄断法的适用尤为重要。1993年和1994年,司法部和联邦贸易委员会在供应商不确定的一些领域联合发布了“反垄断执行政策声明”。对于综合配送系统,反垄断分析的主要焦点是“市场力量”。没有市场力量的系统(即,强迫购买者做购买者在竞争市场中不会做的事情的能力)不会损害消费者,应该没有严重的反垄断风险。当一个网络可能拥有市场力量时,只有当明显的反竞争影响超过新安排所声称的效率效益时,它的活动才可能受到限制。本章的结论是,可能需要强有力的反垄断执法,以促进供应商和他们所服务的管理式医疗计划的综合网络之间的市场竞争。
{"title":"The legal framework for effective competition.","authors":"R A Berenson,&nbsp;D A Hastings,&nbsp;W G Kopit","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Largely because of its indifference to spiraling costs, the professional domination model is being replaced by a market model based on competition among managed care plans and integrated delivery systems. In general, the more fully integrated previously competing providers become--for instance, by assuming financial risk together--the less legal risk is present, because of a decreased possibility of improper conspiratorial or collective behavior. Nevertheless, provider joint ventures and integrated delivery systems face a complex interaction of practical challenges and various legal and regulatory risks. This chapter explores ways in which laws involving fraud and abuse, self-referral, private inurement, corporate practice of medicine, Medicare reimbursement policy, and antitrust enforcement affect typical integrated delivery systems. From a legal standpoint, it might seem logical that the laws regulating health care providers would support and promote integration. A permissive legal environment to foster development of an integrated service network model assumes its development in a delivery system in which networks are at financial risk for the services provided. However, many of the laws and regulations governing integrated provider development were established at a time when joint ventures and other alliances were organizing in a predominantly fee-for-service environment and were generating significant increases in health care costs without producing demonstrable efficiencies or quality enhancements. The results is a fundamental inconsistency in government policy. The demand for collaboration by purchasers and legislatures does not necessarily cause the vast body of health care regulators to revise their concerns that many of the very collaborative activities being encouraged trigger potentially illegal acts and relationships. In a market model, the application of federal and state antitrust laws is especially important. In 1993 and 1994, the Department of Justice and the Federal Trade Commission jointly issued \"Statements of Antitrust Enforcement Policy\" in a number of areas of provider uncertainty. For integrated delivery systems, the primary focus of antitrust analysis is \"market power.\" Systems without market power (i.e., the ability to force a purchaser to do something that the purchaser would not do in a competitive market) cannot harm consumers and should be free from serious antitrust risk. Where a network may have market power, its activities may be limited only if demonstrable anticompetitive effects outweigh the benefits of the efficiencies claimed by the new arrangement. The chapter concludes that vigorous antitrust enforcement may be required to promote market competition among integrated networks of providers and the managed care plans they serve.</p>","PeriodicalId":80306,"journal":{"name":"The Baxter health policy review","volume":"2 ","pages":"235-65"},"PeriodicalIF":0.0,"publicationDate":"1996-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"21895009","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Where does health care reform go from here? An unchartered odyssey. 医疗改革将何去何从?一个未知的奥德赛。
Pub Date : 1996-01-01
S H Altman, U E Reinhardt
{"title":"Where does health care reform go from here? An unchartered odyssey.","authors":"S H Altman,&nbsp;U E Reinhardt","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":80306,"journal":{"name":"The Baxter health policy review","volume":"2 ","pages":"xxi-xxxii"},"PeriodicalIF":0.0,"publicationDate":"1996-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"21894419","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The new organization of the health care delivery system. 卫生保健服务系统的新组织。
Pub Date : 1996-01-01
S M Shortell, K E Hull

The U.S. health care system is restructuring at a dizzying pace. In many parts of the country, managed care has moved into third-generation models emphasizing capitated payment for enrolled lives and, in the process, turning most providers and institutions into cost centers to be managed rather than generators of revenue. While the full impact of the new managed care models remains to be seen, most evidence to date suggests that it tends to reduce inpatient use, may be associated with greater use of physician services and preventive care, and appears to result in no net differences either positive or negative with regard to quality or outcomes of care in comparison with fee-for-service plans. Some patients, however, tend to be somewhat less satisfied with scheduling of appointments and the amount of time spent with providers. There is no persuasive evidence that managed care lowers the rate of growth in overall health care costs within a given market. Further, managed care performance varies considerably across the country, and the factors influencing managed care performance are not well understood. Organized delivery systems are a somewhat more recent phenomenon representing various forms of ownership and strategic alliances among hospitals, physicians, and insurers designed to provide more cost-effective care to defined populations by achieving desired levels of functional, physician-system, and clinical integration. Early evidence suggests that organized delivery systems that are more integrated have the potential to provide more accessible coordinated care across the continuum, and appear to be associated with higher levels of inpatient productivity, greater total system revenue, greater total system cash flow, and greater total system operating margin than less integrated delivery forms. Some key success factors for developing organized delivery systems have been identified. Important roles are played by organizational culture, information systems, internal incentives, total quality management, physician leadership, and the growth of group practices. This chapter describes the growth and evolution of managed care and organized delivery systems, the research evidence regarding managed care and organized delivery systems, and the likely future organization of the health system in light of recent trends and evidence. It also highlights some of the more important public policy implications of the new health care infrastructure.

美国医疗保健系统正在以令人眼花缭乱的速度进行重组。在美国的许多地区,管理式医疗已经进入第三代模式,强调为登记的生命付费,在这个过程中,大多数提供者和机构变成了被管理的成本中心,而不是收入的创造者。虽然新的管理式医疗模式的全面影响仍有待观察,但迄今为止的大多数证据表明,它倾向于减少住院病人的使用,可能与更多地使用医生服务和预防性护理有关,并且与服务收费计划相比,在护理质量或结果方面似乎没有产生积极或消极的净差异。然而,一些患者往往对预约安排和花在医生身上的时间不太满意。没有令人信服的证据表明,在给定的市场中,管理式医疗保健降低了总体医疗保健成本的增长率。此外,全国各地的管理医疗绩效差异很大,影响管理医疗绩效的因素尚未得到很好的理解。有组织的交付系统是最近出现的一种现象,代表了医院、医生和保险公司之间各种形式的所有权和战略联盟,旨在通过实现所需的功能、医生系统和临床整合水平,为特定人群提供更具成本效益的医疗服务。早期证据表明,整合程度更高的有组织的交付系统有可能在整个连续体中提供更容易获得的协调护理,并且与整合程度较低的交付形式相比,似乎具有更高水平的住院生产率、更高的系统总收入、更高的系统总现金流和更高的系统总营业利润率。已经确定了开发有组织的交付系统的一些关键成功因素。组织文化、信息系统、内部激励、全面质量管理、医生领导和团体实践的增长发挥了重要作用。本章描述了管理式医疗和有组织的提供系统的成长和演变,关于管理式医疗和有组织的提供系统的研究证据,以及根据最近的趋势和证据,卫生系统可能的未来组织。它还强调了新的卫生保健基础设施的一些更重要的公共政策影响。
{"title":"The new organization of the health care delivery system.","authors":"S M Shortell,&nbsp;K E Hull","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>The U.S. health care system is restructuring at a dizzying pace. In many parts of the country, managed care has moved into third-generation models emphasizing capitated payment for enrolled lives and, in the process, turning most providers and institutions into cost centers to be managed rather than generators of revenue. While the full impact of the new managed care models remains to be seen, most evidence to date suggests that it tends to reduce inpatient use, may be associated with greater use of physician services and preventive care, and appears to result in no net differences either positive or negative with regard to quality or outcomes of care in comparison with fee-for-service plans. Some patients, however, tend to be somewhat less satisfied with scheduling of appointments and the amount of time spent with providers. There is no persuasive evidence that managed care lowers the rate of growth in overall health care costs within a given market. Further, managed care performance varies considerably across the country, and the factors influencing managed care performance are not well understood. Organized delivery systems are a somewhat more recent phenomenon representing various forms of ownership and strategic alliances among hospitals, physicians, and insurers designed to provide more cost-effective care to defined populations by achieving desired levels of functional, physician-system, and clinical integration. Early evidence suggests that organized delivery systems that are more integrated have the potential to provide more accessible coordinated care across the continuum, and appear to be associated with higher levels of inpatient productivity, greater total system revenue, greater total system cash flow, and greater total system operating margin than less integrated delivery forms. Some key success factors for developing organized delivery systems have been identified. Important roles are played by organizational culture, information systems, internal incentives, total quality management, physician leadership, and the growth of group practices. This chapter describes the growth and evolution of managed care and organized delivery systems, the research evidence regarding managed care and organized delivery systems, and the likely future organization of the health system in light of recent trends and evidence. It also highlights some of the more important public policy implications of the new health care infrastructure.</p>","PeriodicalId":80306,"journal":{"name":"The Baxter health policy review","volume":"2 ","pages":"101-48"},"PeriodicalIF":0.0,"publicationDate":"1996-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"21894423","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Redefining private insurance in a changing market structure. 在不断变化的市场结构中重新定义私人保险。
Pub Date : 1996-01-01
D J Chollet

This discussion on likely changes and challenges for the health insurance industry over the coming decade assumes that significant national reform of health care financing for the privately insured population will not occur--or, if it does, that it will mirror the insurance market reforms that many states already have undertaken. First, the changes in private insurance coverage during the past several years are considered, with particular attention to the erosion of employer-based coverage and to the rising influence of public insurance programs--especially Medicaid--on the private insurance market. Next is a description of the changing web of state laws and regulations governing private health insurance. At this writing, virtually every state has enacted or is considering reforms of the small group market to limit what many perceive as unfair or destructive insurer practices and to set new ground rules for competition among insurance arrangements. The changing nature of private insurance contracts in the United States is considered next. Evolving from conventional fee-for-service contracts, private insurance is increasingly a complex mixture of capitation, partial capitation, and reinsurance of capitated arrangements. Finally, this chapter discusses three issues of increasing importance in shaping the marketplace for private insurers: (1) the federal preemption of states' regulatory authority over self-insured employer plans; (2) emerging state regulation to restructure competition in the health insurance and health care markets; and (3) the growing interest of both federal and state governments in medical savings accounts to finance health insurance and health care spending.

关于健康保险行业在未来十年可能发生的变化和挑战的讨论假设,不会发生针对私人保险人口的重大国家医疗保健融资改革——或者,如果发生了,它将反映许多州已经进行的保险市场改革。首先,考虑了过去几年私人保险覆盖范围的变化,特别关注雇主保险范围的侵蚀以及公共保险计划(特别是医疗补助计划)对私人保险市场的影响日益增加。接下来是对管理私人健康保险的州法律法规变化网络的描述。在撰写本文时,几乎每个州都已颁布或正在考虑对小团体市场进行改革,以限制许多人认为不公平或破坏性的保险公司做法,并为保险安排之间的竞争制定新的基本规则。接下来将讨论美国私人保险合同性质的变化。从传统的按服务收费合同演变而来的私营保险,日益成为一种复杂的组合,包括自筹资金、部分自筹资金和自筹资金安排的再保险。最后,本章讨论了在塑造私人保险公司市场方面日益重要的三个问题:(1)联邦政府对自行投保雇主计划的州监管权力的优先地位;(2)国家对健康保险和医疗保健市场竞争进行重组的新规定;(3)联邦政府和州政府对医疗储蓄账户越来越感兴趣,以资助健康保险和医疗保健支出。
{"title":"Redefining private insurance in a changing market structure.","authors":"D J Chollet","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>This discussion on likely changes and challenges for the health insurance industry over the coming decade assumes that significant national reform of health care financing for the privately insured population will not occur--or, if it does, that it will mirror the insurance market reforms that many states already have undertaken. First, the changes in private insurance coverage during the past several years are considered, with particular attention to the erosion of employer-based coverage and to the rising influence of public insurance programs--especially Medicaid--on the private insurance market. Next is a description of the changing web of state laws and regulations governing private health insurance. At this writing, virtually every state has enacted or is considering reforms of the small group market to limit what many perceive as unfair or destructive insurer practices and to set new ground rules for competition among insurance arrangements. The changing nature of private insurance contracts in the United States is considered next. Evolving from conventional fee-for-service contracts, private insurance is increasingly a complex mixture of capitation, partial capitation, and reinsurance of capitated arrangements. Finally, this chapter discusses three issues of increasing importance in shaping the marketplace for private insurers: (1) the federal preemption of states' regulatory authority over self-insured employer plans; (2) emerging state regulation to restructure competition in the health insurance and health care markets; and (3) the growing interest of both federal and state governments in medical savings accounts to finance health insurance and health care spending.</p>","PeriodicalId":80306,"journal":{"name":"The Baxter health policy review","volume":"2 ","pages":"33-62"},"PeriodicalIF":0.0,"publicationDate":"1996-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"21895012","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Managed care for people with disabilities: caring for those with the greatest need. 对残疾人的管理式护理:照顾那些最有需要的人。
Pub Date : 1996-01-01
S S Wallack, H J Levine, M A McManus, H B Fox, P W Newacheck, R G Frank, T G McGuire

Disability is discussed in terms of three categories: conditions that result from biomedical conditions and chronic, lifelong illnesses; role or social functioning difficulties that result from behavioral, developmental, or brain disorders; and conditions that limit physical functioning. The range and depth of services needed by the disabled result in higher costs of health care for this population. Because their service needs vary so widely, no single program can address all of the needs equally. Currently, no integrated public policy or program is specifically designed to serve people with disabilities. Rather, they are served by a range of programs that provide specific benefits (e.g., health, social services, and income). Section 1 of this chapter provides an overview on extending the concept of managed care to disabled populations. Special attention is paid to the financing of health care, the delivery of care, reforming the health care system, the cost-containment potential of managed care, and the need to align care with the nature of the individual disability. In sections 2 and 3, the current status of managed care for two special populations--children and the mentally ill--is discussed in greater detail. Section 2 addresses the characteristics of chronically ill and disabled children, public and private health insurance coverage of children with disabilities, other public programs for chronically ill children, and current directions and strategic choices for managed pediatric care. Section 3 describes the mentally ill and the system of providers that currently supplies care to them, offers some conclusions regarding how managed care is changing the policy debate in mental health care, assesses the key factors affecting policy choices in managed care, and considers prospects for the future shape of managed behavioral health care.

残疾分为三类:由生物医学疾病和慢性终身疾病引起的残疾;由行为、发育或大脑紊乱引起的角色或社会功能障碍;以及限制身体机能的条件。残疾人所需服务的范围和深度导致这一人群的医疗保健费用增加。由于他们的服务需求千差万别,没有一个项目能够平等地满足所有的需求。目前,没有专门为残疾人服务的综合性公共政策或项目。相反,他们是由一系列提供特定福利的项目(例如,健康、社会服务和收入)服务的。本章第1节概述了将管理式护理的概念扩展到残疾人群。特别关注卫生保健的筹资、提供保健、改革卫生保健系统、管理保健的成本控制潜力以及使保健与个人残疾的性质相一致的必要性。在第2节和第3节中,对两种特殊人群——儿童和精神病患者——的管理式护理的现状进行了更详细的讨论。第2部分阐述了慢性病和残疾儿童的特点,残疾儿童的公共和私人健康保险覆盖范围,慢性病儿童的其他公共项目,以及管理儿科护理的当前方向和战略选择。第3节描述了精神疾病和目前为他们提供护理的提供者系统,提供了一些关于管理式护理如何改变精神卫生保健政策辩论的结论,评估了影响管理式护理政策选择的关键因素,并考虑了管理行为卫生保健未来形态的前景。
{"title":"Managed care for people with disabilities: caring for those with the greatest need.","authors":"S S Wallack,&nbsp;H J Levine,&nbsp;M A McManus,&nbsp;H B Fox,&nbsp;P W Newacheck,&nbsp;R G Frank,&nbsp;T G McGuire","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Disability is discussed in terms of three categories: conditions that result from biomedical conditions and chronic, lifelong illnesses; role or social functioning difficulties that result from behavioral, developmental, or brain disorders; and conditions that limit physical functioning. The range and depth of services needed by the disabled result in higher costs of health care for this population. Because their service needs vary so widely, no single program can address all of the needs equally. Currently, no integrated public policy or program is specifically designed to serve people with disabilities. Rather, they are served by a range of programs that provide specific benefits (e.g., health, social services, and income). Section 1 of this chapter provides an overview on extending the concept of managed care to disabled populations. Special attention is paid to the financing of health care, the delivery of care, reforming the health care system, the cost-containment potential of managed care, and the need to align care with the nature of the individual disability. In sections 2 and 3, the current status of managed care for two special populations--children and the mentally ill--is discussed in greater detail. Section 2 addresses the characteristics of chronically ill and disabled children, public and private health insurance coverage of children with disabilities, other public programs for chronically ill children, and current directions and strategic choices for managed pediatric care. Section 3 describes the mentally ill and the system of providers that currently supplies care to them, offers some conclusions regarding how managed care is changing the policy debate in mental health care, assesses the key factors affecting policy choices in managed care, and considers prospects for the future shape of managed behavioral health care.</p>","PeriodicalId":80306,"journal":{"name":"The Baxter health policy review","volume":"2 ","pages":"351-94"},"PeriodicalIF":0.0,"publicationDate":"1996-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"21895013","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Rationing health care: what it is, what it is not, and why we cannot avoid it. 配给医疗保健:它是什么,它不是什么,为什么我们不能避免它。
Pub Date : 1996-01-01
U E Reinhardt

The word "rationing" has come to play a central role in the national health policy debate. Alas, it is also one of the most misunderstood of words. Its injection into the debate has generated far more heat than light. This chapter reviews the definition of "rationing" preferred by the profession that takes as its task the study of how individuals and society respond to and deal with scarcity, namely, the economics profession. It will be shown that economists usually consider all limits on the distribution of a scarce good or services to be "rationing," whether that limit takes the form of a price barrier or some method of non-price allocation--for example, queues or allocation by lottery. To make a distinction between allocation through freely competitive markets and other forms of resource allocation, economists distinguish between "price rationing" and "non-price rationing." This is a meaningful distinction. Adoption of the economist's definition of "rationing" would greatly clarify the national health policy debate. Next, the discussion turns to the controversial proposition, commonly made by most economists and a handful of their allies in the medical profession, that an economically efficient health care system will inevitably engage in the pervasive withholding of services that may be sought by patients and their physicians, and that it will do so to enhance the quality and efficiency of the health care system overall. If managed competition lives up to its current billing, it will entail rationing of precisely that sort. Unfortunately, the individualist tradition of the United States, as it expresses itself in the tort system, may seriously hinder managed competition from achieving its stated goal. Finally, this chapter offers some conjectures on the approach to rationing likely to be taken by the United States health care system in the twenty-first century. It is argued that, far from having been inconclusive, the most recent congressional debate on health care reform actually gave official sanction to a three-tiered health system, with fairly severe rationing in the bottom tier and virtually none in the top tier. While such tiering has always been present in the U.S. health care system, the phenomenon has hitherto been treated as a blemish to be removed by government--now it will probably remain a permanent fixture.

“定量配给”一词已经在国家卫生政策辩论中发挥了核心作用。唉,这也是最容易被误解的词之一。它对这场辩论的介入产生的热远远大于光。本章回顾了以研究个人和社会如何应对和处理稀缺性为任务的专业(即经济学专业)所偏好的“定量配给”定义。经济学家通常认为对稀缺商品或服务分配的所有限制都是“定量配给”,无论这种限制是以价格壁垒的形式还是以某种非价格分配的方式——例如,排队或抽签分配。为了区分通过自由竞争市场进行的分配和其他形式的资源分配,经济学家区分了“价格配给”和“非价格配给”。这是一个有意义的区别。采用这位经济学家对“定量配给”的定义将极大地澄清国家卫生政策的争论。接下来,讨论转向了一个有争议的命题,这个命题通常是由大多数经济学家和他们在医学界的少数盟友提出的,即一个经济上有效的卫生保健系统将不可避免地普遍拒绝病人和他们的医生可能寻求的服务,而且这样做将提高整个卫生保健系统的质量和效率。如果有管理的竞争符合其目前的账单,它将导致这种定量配给。不幸的是,美国的个人主义传统,正如它在侵权制度中表现出来的那样,可能会严重阻碍管理竞争实现其既定目标。最后,本章对21世纪美国卫生保健系统可能采取的定量配给方法提出了一些猜想。有人认为,最近国会关于医疗改革的辩论非但没有得出结论,反而正式批准了一个三级医疗体系,即在底层实行相当严格的定量配给,而在顶层几乎没有。虽然这种分级制度一直存在于美国的医疗保健体系中,但迄今为止,这种现象一直被视为一个需要政府消除的缺陷——现在,它可能仍将是一个永久的固定现象。
{"title":"Rationing health care: what it is, what it is not, and why we cannot avoid it.","authors":"U E Reinhardt","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>The word \"rationing\" has come to play a central role in the national health policy debate. Alas, it is also one of the most misunderstood of words. Its injection into the debate has generated far more heat than light. This chapter reviews the definition of \"rationing\" preferred by the profession that takes as its task the study of how individuals and society respond to and deal with scarcity, namely, the economics profession. It will be shown that economists usually consider all limits on the distribution of a scarce good or services to be \"rationing,\" whether that limit takes the form of a price barrier or some method of non-price allocation--for example, queues or allocation by lottery. To make a distinction between allocation through freely competitive markets and other forms of resource allocation, economists distinguish between \"price rationing\" and \"non-price rationing.\" This is a meaningful distinction. Adoption of the economist's definition of \"rationing\" would greatly clarify the national health policy debate. Next, the discussion turns to the controversial proposition, commonly made by most economists and a handful of their allies in the medical profession, that an economically efficient health care system will inevitably engage in the pervasive withholding of services that may be sought by patients and their physicians, and that it will do so to enhance the quality and efficiency of the health care system overall. If managed competition lives up to its current billing, it will entail rationing of precisely that sort. Unfortunately, the individualist tradition of the United States, as it expresses itself in the tort system, may seriously hinder managed competition from achieving its stated goal. Finally, this chapter offers some conjectures on the approach to rationing likely to be taken by the United States health care system in the twenty-first century. It is argued that, far from having been inconclusive, the most recent congressional debate on health care reform actually gave official sanction to a three-tiered health system, with fairly severe rationing in the bottom tier and virtually none in the top tier. While such tiering has always been present in the U.S. health care system, the phenomenon has hitherto been treated as a blemish to be removed by government--now it will probably remain a permanent fixture.</p>","PeriodicalId":80306,"journal":{"name":"The Baxter health policy review","volume":"2 ","pages":"63-99"},"PeriodicalIF":0.0,"publicationDate":"1996-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"21895014","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
The Baxter health policy review
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1